Wolverine Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
972
+307
| +46% | +$92.3K | ﹤0.01% | 829 |
|
|
2025
Q1 | $218K | Sell |
665
-5,254
| -89% | -$1.72M | ﹤0.01% | 1024 |
|
|
2024
Q4 | $1.84M | Buy |
5,919
+920
| +18% | +$287K | ﹤0.01% | 375 |
|
|
2024
Q3 | $1.06M | Buy |
4,999
+417
| +9% | +$88.6K | ﹤0.01% | 400 |
|
|
2024
Q2 | $1.28M | Buy |
+4,582
| New | +$1.28M | ﹤0.01% | 346 |
|
|
2024
Q1 | – | Sell |
-4,503
| Closed | -$1.04M | – | 1799 |
|
|
2023
Q4 | $1.04M | Buy |
4,503
+286
| +7% | +$66.2K | ﹤0.01% | 421 |
|
|
2023
Q3 | $616K | Sell |
4,217
-5,566
| -57% | -$813K | ﹤0.01% | 511 |
|
|
2023
Q2 | $2.15M | Buy |
9,783
+4,393
| +82% | +$967K | ﹤0.01% | 203 |
|
|
2023
Q1 | $1.27M | Buy |
+5,390
| New | +$1.27M | ﹤0.01% | 264 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1673 |
|
|
2022
Q3 | – | Sell |
-6,565
| Closed | -$472K | – | 1827 |
|
|
2022
Q2 | $472K | Buy |
6,565
+4,071
| +163% | +$293K | ﹤0.01% | 555 |
|
|
2022
Q1 | $248K | Sell |
2,494
-8,674
| -78% | -$863K | ﹤0.01% | 1089 |
|
|
2021
Q4 | $948K | Buy |
11,168
+6,868
| +160% | +$583K | ﹤0.01% | 606 |
|
|
2021
Q3 | $344K | Buy |
4,300
+1,860
| +76% | +$149K | ﹤0.01% | 1227 |
|
|
2021
Q2 | $237K | Buy |
2,440
+269
| +12% | +$26.1K | ﹤0.01% | 1378 |
|
|
2021
Q1 | $253K | Buy |
+2,171
| New | +$253K | ﹤0.01% | 1345 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1884 |
|
|
2020
Q3 | – | Sell |
-2,075
| Closed | -$213K | – | 1702 |
|
|
2020
Q2 | $213K | Buy |
+2,075
| New | +$213K | ﹤0.01% | 981 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1756 |
|
|
2016
Q3 | – | Sell |
-397
| Closed | -$4K | – | 1623 |
|
|
2016
Q2 | $4K | Buy |
+397
| New | +$4K | ﹤0.01% | 871 |
|